Q3 2010 · —
Revenue$186.64M$186.64M +8.3% vs Q3 2009+4.5% vs Q2 2010
Net Income$16.48M$16.48M +14.2% vs Q3 2009+8.7% vs Q2 2010
EPS Diluted$0.55$0.55 +12.2% vs Q3 2009+10.0% vs Q2 2010
Gross Profit$117,447,000—
Operating Income$27,309,000+14.6%
Operating Cash Flowderived$29,646,000+4.5%
Free Cash Flowderived$22,440,000−1.1%
Margins · derived
Gross margin62.9%
Operating margin14.6%+0.8 pt vs Q3 2009
Net margin8.8%+0.5 pt vs Q3 2009
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2010 | Q3 2009 |
|---|---|---|
| Revenue | $186.64M | $172.29M |
| Net Income | $16.48M | $14.43M |
| EPS Diluted | $0.55 | $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR